Effectiveness of intravenous insulin pump therapy combined with levofloxacin in diabetic patients with lung infections: A retrospective observational study
Abstract
Despite progress in treating diabetes-related lung infections with antimicrobials and glycemic control, outcomes remain poor – prolonged hospitalization, high relapse rates, and > 20% mortality in severe cases. Novel therapies addressing both metabolic and infectious challenges are urgently needed. This study evaluates the efficacy of combining intravenous insulin pump therapy with levofloxacin for such patients. A total of 223 patients diagnosed with diabetes mellitus (DM) with lung infection were divided into 2 groups: the control group, which underwent levofloxacin and oral metformin hydrochloride, and the observation group, which received intravenous insulin pump therapy on basis of the above treatment. The outcomes of these 2 groups were compared and evaluated. After treatment, the observation group exhibited significantly lower levels of hemoglobin A1c (HbA1c), 2-hour postprandial blood glucose (2hPG), fasting blood glucose (FBG), acute physiology and chronic health evaluation II (APACHE II) score, serum amyloid A (SAA), serum ferritin (SF), procalcitonin (PCT), thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (APTT). Conversely, the levels of fibrinogen (FIB), as well as CD4+/CD8+, immunoglobulin (Ig) A, IgG and IgM were significantly higher in the observation group. Furthermore, the effective treatment rate in the observation group was markedly superior to that in the control group. Subgroup analyses confirmed the consistent benefit of…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 223 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.